Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
work (e.g. adenovirus), and immune readouts like ELISA, ELISpot, or flow cytometry. Experience with advanced vaccine platforms, such as multivalent constructs, polycistronic systems, high-capacity
-
with different diseases in diverse populations and to identify potential therapeutic targets. This is an exciting opportunity to contribute to a programme of research that assess the causal relevance
-
thesis by 31 August 2025), and demonstrate an ability to teach high-achieving students on a broad range of topics. Good team-working and organisational skills are essential, as are excellent
-
hepatitis and liver disease. This post is funded by the National Institute for Health and Care Research (NIHR) as part of a significant research programme that leverages large-scale healthcare datasets
-
the possibility of extension subject to funding. The UK Programme of Laser Inertial Fusion Technology for Energy (UPLiFT) is a 4 year £10M research programme funded by the UK government’s Department for Energy
-
knowledge and tools for non-equilibrium flows for hypersonic vehicles. The research will provide unique and high-quality experimental data for expanding high temperature flows. Alongside this, the proposal
-
. The post is funded by EPSRC Grant EP/X00967X/1 and is fixed-term for two years. EDOL will establish a world-class Observatory of 2,000 representative GB homes with high resolution, longitudinal, technical
-
Mobility Reading Group led by Nobuko Yoshida. The successful candidate will be located in the Department of Computer Science Reporting to Professor Nobuko Yoshida, the post holder will be responsible
-
with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research Council (MRC), Wellcome Trust and National Institute
-
applications. In this role, you will take the lead on an independent project within our broader research programme. Your work will centre on identifying and characterising novel regulators of the immune response